
Patients who took popular weight loss drugs were 12 per cent less likely to develop Alzheimer’s disease but were more at risk of arthritic, kidney and pancreatic disorders, according to the largest ever study of the medicines’ widening impact.
A coh

Patients who took popular weight loss drugs were 12 per cent less likely to develop Alzheimer’s disease but were more at risk of arthritic, kidney and pancreatic disorders, according to the largest ever study of the medicines’ widening impact.
A coh